Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Patients typically start at a low dose and increase gradually
This is not a category to approach casually
Early-phase clinical trial data, including results from a Phase 2 randomised controlled trial published in The New England Journal of Medicine in 2023 (Jastreboff et al., NEJM 2023), demonstrated significant weight reduction in adults with obesity (without type 2 diabetes), with participants receiving the highest dose losing a mean of approximately 24% of their body weight over 48 weeks
Hypoglycemia (Low Blood Sugar) IGF-1 mimics the action of insulin by promoting glucose uptake into muscle cells
US$ 24.33
US$ 23.45
US$ 29.10
